Anne Luetkemeyer, MD

Trials

Studies that name Anne Luetkemeyer, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:50 UTC. Open this list on ClinicalTrials.gov

• Ph4
  NCT03980223 · Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men

  University of California, San Francisco · completed · Gonorrhea, Chlamydia, Syphilis · principal investigator
• Ph4
  NCT02206932 · A Study of the Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

  University of California, San Francisco · withdrawn · Hepatitis C, Chronic, HIV CDC Category A1 · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 05:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
  R01AI143439 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CONNIE L CELUM, Anne Frey Luetkemeyer · fiscal years 2019 to 2023
  Named on NCT03980223